Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| R01HL132448 | Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the gut microbiota-brain-immune axis | 1 | 2025 |
| R01HL134828 | Novel exosomal niches for alveolar stem cell-bassed repair of ARDS | 1 | 2025 |
| R01HL145372 | Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosis | 1 | 2025 |
| R01HL145408 | Alveolar Epithelial Cell Dysfunction in Pulmonary Fibrosis: Leveraging SFTPC Mutations for Discovery of Molecular and Cellular Targets | 1 | 2025 |
| R01HL149883 | Mechanisms of regulatory T cell-mediated recovery from severe viral pneumonia | 1 | 2025 |
| R01HL155095 | Airway Structural Cells and Corticosteroid Resistance in Asthma | 1 | 2025 |
| R01HL158796 | New data science approaches to visualize and understand the impact of the microbiome on risk of graft-versus-host disease | 1 | 2025 |
| R01LM013763 | Investigation of the landscape of immunosequencing and its clinical relevance through novel immunoinformatic approaches | 1 | 2025 |
| R01MH110360 | Broad-spectrum HIV gene editing strategies in peripheral and brain reservoirs | 1 | 2025 |
| R01NS034239 | Neuroprotective Immunity and HIV Dementia | 1 | 2025 |
| R01NS070711 | Nociceptive Mechanisms Underlying Sickle Cell Pain | 1 | 2025 |
| R01NS124594 | Mechanism and therapeutic potential of microglia regulation in glioblastoma | 1 | 2025 |
| R21DK138390 | Catheter-associated molecular patterns and arteriovenous fistula failure | 1 | 2025 |
| R24AA012885 | Integrative Liver Cell Core | 1 | 2025 |
| R24AA019431 | Monkey Alcohol Tissue Research Resource (MATRR) | 1 | 2025 |
| R24AI067039 | CFAR Network of Integrated Clinical Systems (CNICS) | 1 | 2025 |
| R24HD000836 | Laboratory of Developmental Biology | 1 | 2025 |
| R35CA197594 | Synergistic role of signaling and epigenetics in leukemic transformation | 1 | 2025 |
| R35CA197623 | Targeting intratumor heterogeneity in breast cancer | 1 | 2025 |
| R35CA197695 | Translating genomic discoveries to improved outcomes for high risk acute leukemia | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=18